Press release
Germany Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and Forecast to 2025
Germany IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.4% during the forecast period. The growing IBD patient population in the region is one of the major driving forces for the growth of the market in the country. According to the national institutes of health, the prevalence of Crohn's disease in Germany was estimated to be 322 per 100,000 in Germany in 2018. Moreover, the growing demand for quality healthcare services in the region is another factor boosting the germany IBD market. The healthcare expenditure in Germany has also been increasing significantly in the past years. A similar trend is expected to be followed in the future. This is expected to be one of the key reasons which are estimated to increase the inflow of R&D funds in inflammatory diseases such as IBD in the future.Get Free Sample Copy @ https://www.omrglobal.com/request-sample/germany-ibd-inflammatory-bowel-disease-therapeutics-market
Germany IBD therapeutics market is segmented on the basis of disease type and treatment type. The disease type segment includes ulcerative colitis and Crohn's disease. Crohn's disease segment is estimated to dominate the market. The growth of the segment is attributed to the comparatively higher incidence of Crohn's disease than ulcerative colitis. For Crohn's and ulcerative colitis, the development of minimally invasive methods has been evolved with more caution as compared to other colorectal diseases. This is primarily due to disease-related characteristics that are concerned with IBD. The treatment type segment is further segmented into anti-inflammatory drugs and surgery.
A Full Report of Germany Inflammatory Bowel Disease (IBD) Therapeutics Market is Available at: https://www.omrglobal.com/industry-reports/germany-ibd-inflammatory-bowel-disease-therapeutics-market
The companies which are contributing to the growth of the Germany IBD therapeutics market include AbbVie Inc., Allergan, PLC, Boehringer Ingelheim International GmbH, Eli Lilly and Co., Johnson & Johnson Services Inc., Pfizer Inc., Pharmacosmos A/S, Sanofi S.A., and others.
Market Segmentation
Germany IBD Therapeutics Market by Disease Type
Ulcerative Colitis
Crohn's Disease
Germany IBD Therapeutics Market by Treatment Type
Surgery
Anti- Inflammatory Drug Administration
Steroids
Immunosuppressant
Biological Drugs
Amino salicylates
Others
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/germany-ibd-inflammatory-bowel-disease-therapeutics-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Germany Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and Forecast to 2025 here
News-ID: 2025476 • Views: …
More Releases from Orion Market Research
Cell Lysis Market Size, Trends, Latest Insights, Analysis and Forecast 2024-2031
The global cell lysis market is anticipated to grow at a considerable CAGR of 8.6% during the forecast period. The key factors that are contributing to the market growth are the growing number of strategies adopted by key players operating in the market. The companies are adopting mergers, acquisitions, collaboration, and new technology-based product development among others. For instance,
• In May 2022, Tethis S.p.A has launched See.d which is the first…
Textile Market Is Expected to Exhibit Significant Growth Over 2031 / Aditya Birl …
Textile Market is projected to grow at a CAGR of 4.8% during the forecast period. The textile sector is an ever-growing market with remarkable growth prospects almost all across the globe. Favourable demographics, increasing per capita income, and a shift in preference toward branded products to drive demand for textile, globally. Superior quality and advantageous trade policies are also estimated to play an imperative role and boost textile exports.
Growth in…
Stuffed Animal & Plush Toys Market Size, Share, Trends, Demand, Segments, Leadin …
The global stuffed animal & plush toys market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period (2024-2031). The offline distribution channel was the largest segment in the stuffed animal & plush toys market. Offline distribution channels include gift stores, toy stores, hypermarkets, specialty stores, and others. The availability of a wide range of products in these stores is the key growth-driving factor for the segment. Moreover,…
Specialty Paper Market Update Report 2024| Industry Trends, Demand, Leading Comp …
Specialty Paper Market is projected to grow at a CAGR of over 4% during the forecast period. The key factors that drive the growth of the market include the growth in the labelling and packaging industries. The majority of paper used in the packaging and labelling industry is specialty paper. The rise in disposable and changing lifestyles along with the increased demand for specialty papers in food service, packaging, and…
More Releases for IBD
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,…
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.
Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx…
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per…
France Inflammatory Bowel Disease (IBD) Therapeutics Market Size, Growth and For …
France IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.6% during the forecast period. The growing IBD patient population is one of the major driving forces for the growth of the market in the country. According to the National Institutes of, Health, the total number of cases associated with Crohn's disease in France were registered to be around 72,522 in 2017. This signifies the opportunity…
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and…
Canada Inflammatory Bowel Disease (IBD) Market Share, Size & Forecast to 2025
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn's disease,…
